Share: Facebook Twitter LinkedIn
Activity Provided By:

Relias LLC

Expert Illustrations & Commentaries: Exploring Novel Approaches to Care for Long-Chain Fatty Acid Oxidation Disorder (LC-FAOD)

Access Activity

Overview / Abstract:

Target Audience
This educational activity is directed toward pediatricians, primary care physicians, endocrinologists, metabolic dieticians, neurologists, neuromuscular specialists, nurse practitioners, physician assistants, and additional health care professionals involved in the care of patients with metabolic disorders.

Activity Overview
Long-chain fatty acid oxidation disorders (LC-FAODs) are caused by defects in the metabolic pathway that converts stored long-chain fatty acids into energy within muscles and other cells, leading to a deficiency in mitochondrial energy production during times of physiologic stress and fasting. LC-FAODs cause serious clinical complications, including cardiomyopathy, recurrent episodes of rhabdomyolysis, weakness, hepatic failure, hypoglycemia, and hyperammonemia. These complications have persisted despite decades of dietary therapy, a diet rich in even-carbon, medium- chain triglycerides (MCT), or a combination of both. Premature mortality may reach 60% to 90% in patients with these diseases.

In this online, on-demand CME activity, two faculty experts discuss the pathophysiology of LC-FAODs, diagnosis and clinical presentation, and current treatment options for patients with LC-FAODs. With new therapies and multispecialty care, these patients can have longer, higher quality lives.

Learning Objectives
Upon successful completion of this activity, you should be better prepared to:

Determine clinical signs and testing approaches to facilitate LC-FAOD diagnosis
Explain the mechanistic rationale that underlies the application of new approved therapy for the treatment of LC-FAOD
Evaluate data regarding the safety and efficacy results from clinical trials that evaluate current treatment strategies among patients with LC-FAOD
Describe the clinical importance of recent trial findings in the context of evolving treatment standards in the field of LC-FAOD management

Expiration

Jan 31, 2022

Discipline(s)

Physician CME

Format

Online

Credits / Hours

0.75

Accreditation

ACCME

Presenters / Authors / Faculty

Barbara K. Burton, MD
Professor of Pediatrics, Division of Genetics, Birth Defects and Metabolism
Ann & Robert H. Lurie Children’s Hospital
Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, IL

Jerry Vockley, MD, PhD
Professor of Human Genetics
University of Pittsburgh
Chief of Medical Genetics
Director of the Center for Rare Disease Therapy
UPMC Children's Hospital of Pittsburgh
Cleveland Family Endowed Chair in Pediatric Research
Pittsburgh, PA

Sponsors / Supporters / Grant Providers

Physicians’ Education Resource®, LLC, Ultragenyx Pharmaceutical Inc.

Keywords / Search Terms

Relias LLC Endocrinology, Genetics, Genetic Disorders, Metabolic Disorders, Neonatology, Neonatal, Nutrition, Pediatrics Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map